Klinger Shannon Thyme bought MRNA
August 28, 2026 · Form 4 insider transaction
Klinger Shannon Thyme bought 329 shares of Moderna, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
329
Price
N/A
Total value
N/A
InsiderKlinger Shannon Thyme
Role—
CompanyModerna, Inc. (MRNA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 28, 2026
Filing dateAugust 31, 2026
Shares owned after74,289
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.